v3.25.0.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Millions
Total
Common Stock  
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
(Accumulated Deficit) Retained Earnings
Common shares outstanding, beginning balance (in shares) at Dec. 31, 2021 [1]   1,258,971,590      
Balance, beginning of the year at Dec. 31, 2021 $ 11,133 $ 8,040 $ 161 $ (6) $ 2,938
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) [1]   3,126,869      
Exercise of stock options 17 $ 34 (17)    
Stock-based compensation 549   549    
Vesting of restricted share units (in shares) [1]   7,380,507      
Vesting of restricted share units $ 0 $ 471 (471)    
Issuance of the Founder share (in shares) [1] 1        
Issuance of shares related to business acquisitions (in shares) [1]   5,649,600      
Issuance of shares related to business acquisitions $ 10 $ 202 (192)    
Net income and comprehensive income (loss) for the year (3,470)     (10) (3,460)
Common shares outstanding, ending balance (in shares) at Dec. 31, 2022 [1]   1,275,128,567      
Balance, end of the year at Dec. 31, 2022 $ 8,239 $ 8,747 30 (16) (522)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 3,915,216 3,915,216 [1]      
Exercise of stock options $ 60 $ 109 (49)    
Stock-based compensation 615   615    
Vesting of restricted share units (in shares) [1]   7,288,043      
Vesting of restricted share units 0 $ 335 (335)    
Issuance of shares related to business acquisitions (in shares) [1]   238,468      
Issuance of shares related to business acquisitions 0 $ 10 (10)    
Net income and comprehensive income (loss) for the year 152     20 132
Common shares outstanding, ending balance (in shares) at Dec. 31, 2023 [1]   1,286,570,294      
Balance, end of the year at Dec. 31, 2023 $ 9,066 $ 9,201 251 4 (390)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options (in shares) 2,576,628 2,576,628 [1]      
Exercise of stock options $ 61 $ 89 (28)    
Stock-based compensation 430   430    
Vesting of restricted share units (in shares) [1]   5,433,218      
Vesting of restricted share units (4) $ 344 (348)    
Net income and comprehensive income (loss) for the year 2,005     (14) 2,019
Common shares outstanding, ending balance (in shares) at Dec. 31, 2024 [1]   1,294,580,140      
Balance, end of the year at Dec. 31, 2024 $ 11,558 $ 9,634 $ 305 $ (10) $ 1,629
[1] Share amounts as of December 31, 2021 have been retrospectively adjusted to reflect the share split ("Share Split") effected in June 2022. See Note 19 for details.